ArteFill is a novel, third-generation polymethylmethacrylate (PMMA) injectable filler with unique properties. When compared with predecessor materials, ArteFill demonstrates improved biocompatibility as a result of more uniform PMMA microsphere size and shape. This translates into less adverse events after placement. ArteFill can provide a permanent volume enhancement by stimulation of fibroblasts that encapsulate nonabsorbable microspheres with collagen deposition. Currently, ArteFill is FDA approved for permanent augmentation of moderately deep nasolabial folds. It is also commonly used off-label for augmentation of other skin creases and regional areas of volume deficiency, such as the tear trough-malar and marionette line-prejowl sulcus regions. The key to success with ArteFill is a conservative approach with avoidance of overcorrection. Proper technique includes deep dermal to subcutaneous placement with full correction achieved gradually over several treatments. Complications are mostly limited to nodule formation, which is easily managed in most cases with conservative intervention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/s-0029-1220651 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multiple Cases of Facial Disfigurement From Filler Use and One Injector.
Ophthalmic Plast Reconstr Surg
July 2023
USC Roski Eye Institute, University of Southern California Keck School of Medicine, Los Angeles, California.
Purpose: To present a case of facial disfigurement from an injectable permanent filler and describe the consequences to patients exposed to the same injector (common source outbreak).
Methods: Case report and discussion of a common source outbreak after a group of persons developed complications years after permanent filler given by one injector.
Results: A 39-year-old transgender model underwent polymethylmethacrylate (Artefill) facial filler injections to the lips, cheeks, and chin in 2018.
Non-Hyaluronic Acid Fillers for Midface Augmentation: A Systematic Review.
Facial Plast Surg
August 2021
Department of Otolaryngology-Head and Surgery, St. Elizabeth's Medical Center, Brighton, Massachusetts.
There has been an increasing role in the use of injectable fillers for rejuvenation of the aging face. In this systematic review, we aim to evaluate the existing literature related to soft tissue fillers of the midface. Specifically, we focus on the non-hyaluronic acid fillers including polymethylmethacrylate (PMMA), poly-L-lactic acid (PLLA), calcium hydroxyapatite (CaHA), and autologous fat.
View Article and Find Full Text PDFHistologic Characterization of Polymethylmethacrylate Dermal Filler Biostimulatory Properties in Human Skin.
Dermatol Surg
December 2019
Compass Dermatopathology, San Diego, California.
Background: Little literature exits on the mechanism of action of implanted polymethylmethacrylate (PMMA) filler.
Objective: To characterize PMMA-induced dermal extracellular matrix production in the skin.
Materials And Methods: Single-center, open-label prospective study in healthy volunteers undergoing removal of redundant skin was injected intradermally and subdermally with PMMA dermal filler (Bellafill).
Complications and Litigation Associated With Injectable Facial Fillers: A Cross-Sectional Study.
J Oral Maxillofac Surg
January 2020
Director, Beau Visage Med Spa; Greater Waterbury OMS; and Associate Clinical Professor, Department of Oral and Maxillofacial Surgery, University of Connecticut, Cheshire, CT. Electronic address:
Purpose: Soft-tissue injectable fillers are a popular treatment option for patients seeking minimally invasive facial rejuvenation. The use of soft-tissue fillers has increased significantly in the past 10 years. In 2017 alone, clinicians administered nearly 2.
View Article and Find Full Text PDFForeign-Body Granulomata Caused by Injected Permanent Filler Masquerading as Cutaneous Sarcoidosis.
Ophthalmic Plast Reconstr Surg
January 2020
Department of Ophthalmology, UT Southwestern Medical Center.
Foreign-body granuloma formation following filler injections is most commonly seen with permanent fillers; these reactions can occur years following the injections and often require either an intralesional steroid injection or surgical excision. The authors present a case of a 75-year-old woman with a history of systemic sarcoidosis previously treated with numerous immunosuppressive medications who was examined for bilateral infraorbital nodules and swelling that were unresponsive to treatment. She underwent a bilateral anterior orbitotomy through a transconjunctival approach with mass excision.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!